Kbc Group Nv Gilead Sciences, Inc. Transaction History

Kbc Group Nv

$33.1 Billion
Q3 2024

A detailed history of Kbc Group Nv transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Kbc Group Nv holds 2,282,519 shares of GILD stock, worth $214 Million. This represents 0.58% of its overall portfolio holdings.

Number of Shares

2,282,519

Previous 3,627,216 37.07%

Holding current value

$214 Million

Previous $249 Million 23.1%

% of portfolio

0.58%

Previous 0.75%

44 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	SELL	$66.59 - $83.99 $89.5 Million - $113 Million	-1,344,697 Reduced 37.07%	2,282,519 $191 Million
Q2 2024 Jul 17, 2024	BUY	$63.15 - $72.88 $29.6 Million - $34.1 Million	468,039 Added 14.82%	3,627,216 $249 Million
Q1 2024 May 08, 2024	BUY	$71.58 - $87.29 $124 Million - $152 Million	1,737,617 Added 122.23%	3,159,177 $231 Million
Q4 2023 Feb 13, 2024	SELL	$73.27 - $83.09 $578,539 - $656,078	-7,896 Reduced 0.55%	1,421,560 $115 Million
Q3 2023 Feb 15, 2024	SELL	$73.94 - $80.67 $15.6 Million - $17 Million	-210,700 Reduced 14.56%	1,236,755 $92.7 Million
Q2 2023 Feb 15, 2024	BUY	$76.01 - $86.7 $49.5 Million - $56.5 Million	651,638 Added 81.88%	1,447,455 $112 Million
Q2 2023 Jul 28, 2023	BUY	$76.01 - $86.7 $38.5 Million - $43.9 Million	506,824 Added 54.93%	1,429,456 $110 Million
Q1 2023 Feb 14, 2024	BUY	$77.31 - $88.08 $6.13 Million - $6.98 Million	79,280 Added 9.3%	932,020 $77.3 Million
Q1 2023 May 04, 2023	BUY	$77.31 - $88.08 $11.7 Million - $13.3 Million	151,143 Added 19.59%	922,632 $76.6 Million
Q4 2022 Feb 14, 2024	BUY	$62.32 - $89.47 $5.29 Million - $7.59 Million	84,842 Added 11.05%	852,740 $73.2 Million
Q3 2022 Feb 15, 2024	SELL	$59.54 - $68.01 $37.3 Million - $42.6 Million	-625,743 Reduced 44.02%	795,817 $49.1 Million
Q3 2022 Nov 08, 2022	BUY	$59.54 - $68.01 $1.36 Million - $1.55 Million	22,765 Added 3.04%	771,489 $47.6 Million
Q2 2022 Feb 14, 2024	BUY	$57.72 - $65.01 $4.48 Million - $5.04 Million	77,533 Added 11.23%	767,898 $47.5 Million
Q2 2022 Jul 26, 2022	BUY	$57.72 - $65.01 $3.37 Million - $3.79 Million	58,359 Added 8.45%	748,724 $46.3 Million
Q1 2022 Feb 14, 2024	SELL	$57.92 - $72.58 $12.5 Million - $15.6 Million	-214,959 Reduced 23.74%	690,365 $41 Million
Q1 2022 May 06, 2022	SELL	$57.92 - $72.58 $12.5 Million - $15.6 Million	-214,959 Reduced 23.74%	690,365 $41 Million
Q4 2021 Feb 14, 2024	SELL	$64.88 - $73.64 $33.5 Million - $38 Million	-516,236 Reduced 36.31%	905,324 $65.7 Million
Q4 2021 Feb 03, 2022	BUY	$64.88 - $73.64 $4.96 Million - $5.63 Million	76,445 Added 9.22%	905,324 $65.7 Million
Q3 2021 Nov 10, 2021	BUY	$67.69 - $73.03 $13.6 Million - $14.7 Million	200,988 Added 32.01%	828,879 $57.9 Million
Q2 2021 Aug 11, 2021	BUY	$63.47 - $69.35 $7.26 Million - $7.93 Million	114,391 Added 22.28%	627,891 $43.2 Million
Q1 2021 Apr 26, 2021	BUY	$60.0 - $68.46 $2.35 Million - $2.68 Million	39,093 Added 8.24%	513,500 $33.2 Million
Q4 2020 Feb 10, 2021	SELL	$56.65 - $64.55 $4.76 Million - $5.42 Million	-84,023 Reduced 15.05%	474,407 $27.6 Million
Q3 2020 Oct 28, 2020	BUY	$62.1 - $78.08 $1.75 Million - $2.2 Million	28,189 Added 5.32%	558,430 $35.3 Million
Q2 2020 Aug 10, 2020	SELL	$72.34 - $84.0 $5.62 Million - $6.52 Million	-77,665 Reduced 12.78%	530,241 $40.8 Million
Q1 2020 May 04, 2020	SELL	$62.63 - $80.22 $5.06 Million - $6.48 Million	-80,746 Reduced 11.73%	607,906 $45.4 Million
Q4 2019 Feb 11, 2020	SELL	$61.62 - $67.78 $8.02 Million - $8.82 Million	-130,094 Reduced 15.89%	688,652 $44.7 Million
Q3 2019 Nov 07, 2019	BUY	$62.51 - $69.0 $51 Million - $56.3 Million	815,845 Added 28122.89%	818,746 $51.9 Million
Q2 2019 Dec 03, 2019	SELL	$61.87 - $69.38 $25.5 Million - $28.6 Million	-412,461 Reduced 99.3%	2,901 $196,000
Q2 2019 Jul 30, 2019	BUY	$61.87 - $69.38 $25.5 Million - $28.6 Million	412,461 Added 14217.89%	415,362 $0
Q1 2019 Dec 03, 2019	SELL	$62.53 - $70.05 $22.3 Million - $25 Million	-357,138 Reduced 99.19%	2,901 $189,000
Q1 2019 May 10, 2019	BUY	$62.53 - $70.05 $22.3 Million - $25 Million	357,138 Added 12310.86%	360,039 $0
Q4 2018 Dec 03, 2019	SELL	$60.54 - $79.0 $22.8 Million - $29.7 Million	-376,531 Reduced 99.24%	2,901 $181,000
Q4 2018 Jan 31, 2019	BUY	$60.54 - $79.0 $22.8 Million - $29.8 Million	376,611 Added 13350.27%	379,432 $23.7 Million
Q3 2018 Dec 03, 2019	SELL	$71.28 - $78.92 $30.7 Million - $33.9 Million	-430,101 Reduced 99.35%	2,821 $218,000
Q3 2018 Nov 14, 2018	BUY	$71.28 - $78.92 $30.7 Million - $33.9 Million	430,101 Added 15246.4%	432,922 $0
Q2 2018 Dec 03, 2019	SELL	$64.88 - $75.68 $13.4 Million - $15.7 Million	-207,149 Reduced 98.66%	2,821 $200,000
Q2 2018 Aug 03, 2018	BUY	$64.88 - $75.68 $13.4 Million - $15.7 Million	207,149 Added 7343.11%	209,970 $0
Q1 2018 Dec 03, 2019	SELL	$72.84 - $88.8 $16.4 Million - $20 Million	-225,100 Reduced 98.76%	2,821 $213,000
Q1 2018 May 09, 2018	BUY	$72.84 - $88.8 $16.4 Million - $20 Million	225,100 Added 7979.44%	227,921 $0
Q4 2017 Dec 03, 2019	SELL	$71.15 - $83.52 $18 Million - $21.1 Million	-252,506 Reduced 98.9%	2,821 $202,000
Q4 2017 Feb 07, 2018	BUY	$71.15 - $83.52 $18 Million - $21.1 Million	253,076 Added 11242.83%	255,327 $0
Q3 2017 Dec 03, 2019	SELL	$72.11 - $85.47 $53.4 Million - $63.3 Million	-740,331 Reduced 99.7%	2,251 $182,000
Q3 2017 Nov 13, 2017	BUY	$72.11 - $85.47 $53.4 Million - $63.3 Million	740,331 Added 32888.98%	742,582 $0
Q2 2017 Dec 03, 2019	BUY	N/A	2,251	2,251 $159,000

Others Institutions Holding GILD

# of Institutions

1,926

Shares Held

992M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $118B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

News

Stay updated on Kbc Group Nv with notifications on news.

Account